Pharmaceutical Anti-counterfeiting Technologies: Market Analysis 2012-2022

October 2012 | 145 pages | ID: PDD19B69FF0EN
Visiongain

Abstracts

Announcing developments and commercial prospects for medical anti-counterfeiting

Where is the pharma anti-counterfeiting industry heading? Visiongain's updated report gives you forecasted revenues to 2022 and shows you trends, opportunities and industry prospects.

Our study investigates technologies to tackle drug counterfeiters. It lets you assess projected sales data at overall world market, submarket and national level. There you investigate the most lucrative areas in that industry and market, seeing future outlooks.

Forecasts and other analyses to help you stay ahead in knowledge

In our investigation you find revenue forecasting to 2022, growth rates and market shares. Also, you see qualitative analysis (inc. SWOT), products, developments and business outlooks. You receive 34 tables, 36 charts and two research interviews.

You can stay ahead in knowledge, benefiting your research and analyses. The following sections highlight what you discover in our report.

You find prospects for world-level submarkets

In addition to analyses of the overall world market, you see revenue forecasting of five world-level submarkets to 2022:

• Security printing
• RFID (radio frequency identification)
• Taggants
• Holograms/OVD (optical variable devices)
• Other pharma anti-counterfeiting technologies.

Our investigation shows business research and analysis with individual revenue forecasts and discussions. See how sales of verification technology can increase.

The work also breaks overall world revenue into leading national and regional markets.

What are the prospects in leading countries?

Events and progress worldwide will influence the market, especially rising demand for supply chain security measures such as track-and-trace systems. There will be many opportunities for stakeholders.

You discover individual revenue forecasts to 2022 for these geographical markets:

• US
• Japan
• Germany, France, UK, Italy and Spain (EU5 countries, as a group)
• Brazil, Russia, India and China (BRIC nations).

The launch of new technology from 2012 onwards will benefit regional and national markets. Greater uptake of existing technology worldwide will also stimulate the industry and market. Find where sales growth can occur and what will stimulate it.

What issues affect the industry and market from 2012 onwards?

Our study lets you assess trends and outlooks. You find discussions of issues and developments from 2012, looking ahead:

• Security and efficiency of the pharma supply chain
• Wholesalers and other pharma intermediaries
• Actions taken by pharma companies
• Trading channels and drug counterfeiters
• Parallel trade of medical products
• Activities of trade bodies and governmental organisations
• Standards, regulations and policies.

You see discussions of social, technological, economic and political matters, with emphasis on competing organisations and those shaping policy. Find out what the future holds.

Discover leading companies and potential for market growth

Overall world revenue for that commercial area will reach $1.2bn in 2015, our report forecasts. Rising concerns about counterfeit drugs worldwide from 2012 to 2022 will stimulate demand for drug security, authentication and verification solutions.

In our report you find discussions of 3M, Authentix, Colorcon, NanoGuardian, Thermo Scientific and other organisations. Also, you see our interviews with two companies.

This decade, many opportunities and benefits will occur for the pharma industry and technology suppliers. Our work shows and explains.

Seven ways Pharmaceutical Anti-counterfeiting Technologies: Market Analysis 2012-2022 helps you

To sum up, our report gives you the following knowledge on the topic:

• Forecasted revenues to 2022 for the overall world market and 5 submarkets - find the industry's commercial prospects
• Market forecasting to 2022 for US, Japan, EU5 countries (as a group), Brazil, Russia, India and China - see national and regional prospects
• Profiles of 17 prominent companies - assess product ranges, developments and strategies
• Opinions on the sector - discover our interviews with the industry
• Investigation of competition and opportunities influencing sales
• Discussions of what stimulates and restrains the industry and market
• Prospects for established companies and those seeking to launch products.

For understanding the industry and market, you can use our report's independent analyses to help your decisions. Also, you receive information found only in our study.

With our report you are less likely to fall behind in knowledge. You see where prospects are lucrative and revenue growth is likely.

Discover how our work could benefit your research and analyses, saving you time too.

Ordering now lets you investigate prospects for pharma anti-counterfeiting technology

Visiongain's study is for everyone needing analysis of the industry and market for technologies to counter fake drugs. You find data, trends and predictions. Please order our report now.

Contents

1. EXECUTIVE SUMMARY

1.1 Review of the Pharmaceutical Anti-counterfeiting Technologies Market
1.2 Aims, Scope and Format of Report
1.3 Research and Analysis Methods

2. INTRODUCTION TO DRUG COUNTERFEITING

2.1 Pharmaceutical Drug Counterfeiting
2.2 The Most Commonly Counterfeited Drugs by Region
2.3 Types of Counterfeit Drugs
  2.3.1 Substandard Drugs as Counterfeits
  2.3.2 Active Pharmaceutical Ingredients (APIs)
    2.3.2.1 Heparin Contamination
    2.3.2.2 API Legislation
2.4 How Are Drugs Counterfeited?
  2.4.1 Why Are Drugs Counterfeited?
  2.4.2 Methods for Producing Counterfeit Drugs
  2.4.3 Moving Counterfeit Drugs into the Supply Chain
  2.4.4 The Pharmaceutical Distribution System and Corruption
2.5 Online Pharmacies and Drug Counterfeiting
  2.5.1 The Role of Legitimate Online Pharmacies
  2.5.2 Verifying the Authenticity of Online Pharmacies
2.6 The Global Costs of Drug Counterfeiting
  2.6.1 The Effects of Counterfeit Drugs on Consumers
  2.6.2 The Effects of Counterfeit Drugs on Manufacturers
  2.6.3 The Effects of Counterfeit Drugs on Healthcare Providers
  2.6.4 The Effects of Counterfeit Drugs on Governments
  2.6.5 The Effect of Drug Counterfeiting on the Global Pharmaceutical Industry
2.7 What Drives Drug Counterfeiting?
  2.7.1 Drug Counterfeiting Thrives on the Lack of Adequate or Enforceable Legislation
  2.7.2 An Erratic Supply or Shortage of Drugs Promotes Counterfeiting
  2.7.3 The Inappropriate Use of Drugs Creates a Market for Counterfeiting
  2.7.4 High Price Some Medicines Drive People to Cheaper Counterfeit Alternatives
  2.7.5 The Trade of Pharmaceuticals Through Several Intermediaries Helps Hide Counterfeit Drugs
  2.7.6 Trade Through Free-Trade Zones/Free Ports Is an Important Route for Counterfeiters
  2.7.7 Counterfeiters Target Developed Markets
  2.7.8 Parallel Trade - a Counterfeiting Route in Europe

3. LEADING TECHNOLOGIES AND APPLICATIONS

3.1 Passive Technologies 2012
  3.1.1 Visual Inspection as the First Line of Defence Against Drug Counterfeiting
  3.1.2 Holograms as Anti-counterfeiting Technologies
  3.1.3 Overt and Hidden Imaging
  3.1.4 Security Inks as Anti-counterfeiting Technologies
3.2 Active Technologies 2012
  3.2.1 Taggants as Anti-counterfeiting Technologies
  3.2.2 Electromagnetic Tags - Radio Frequency Identification (RFID) as Anti-counterfeiting Technologies
  3.2.3 Mass Encoding
    3.2.3.1 Barcode Applications - Serialisation is Key
    3.2.3.2 Digital Mass Serialisation (DMS)
    3.2.3.3 Digital Mass Encryption (DME)

4. LEADING COMPANIES IN THE FIELD

4.1 3M
  4.1.1 The Anti-counterfeiting Solutions of 3M
4.2 Alien Technology - RFID Technology
4.3 AlpVision - Crytptoglyph Security Solution
4.4 Angstrom Technologies - Security Inks
4.5 Authentix - Brand Protection Solutions
  4.5.1 The Packaging Solutions of Authentix
  4.5.2 Authentix Track-and-Trace Solutions
4.6 Avery Dennison - a Leader in RFID Technologies
4.7 Colorcon
  4.7.1 Colorcon Brand Enhancement Service
  4.7.2 Colorcon's Taggants: On-Dose ID
  4.7.3 Other Identifiers by Colorcon
4.8 Chesapeake - Cortegra Acquisition
4.9 Covectra
  4.9.1 Covectra's Authenti-Track Platform
4.10 Everest Holovisions - Holographic Security
4.11 InkSure Technologies - Taggant Technology
4.12 Intermec - Automatic Information Data Capture
4.13 NanoGuardian
  4.13.1 The NanoEncryption Process
  4.13.2 NanoGuardian Closed-Loop Protection System
  4.13.3 NanoGuardian's Global Collaboration Agreement with Capsugel
4.14 Thermo Scientific (Formerly Ahura Scientific and Polychromix)
  4.14.1 Thermo Scientific's TruScan Technology
4.15 TruTag Technologies
  4.15.1 TruTag's Proprietary Technology
4.16 UPM Raflatac - Smartrac Take Over RFID Business
4.17 Zebra Technologies

5. GLOBAL PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES MARKET 2012-2022

5.1 Overview of the World Anti-counterfeiting Technologies Market 2011-2022
5.2 Pharmaceutical Security Printing Market Forecast 2012-2022
5.3 Pharmaceutical RFID Market Forecast 2012-2022
5.4 Pharmaceutical Taggants Market Forecast 2012-2022
5.5 Pharmaceutical Hologram/OVD Market Forecast 2012-2022
5.6 Other Pharmaceutical Anti-counterfeiting Technologies Market Forecast 2012-2022

6. LEADING NATIONAL MARKETS 2012-2022

6.1 The Global Counterfeiting Problem 2011
6.2 Forecasts for the Leading National Markets 2012-2022
  6.2.1 US Anti-counterfeiting Technologies Market Forecast 2012-2022
  6.2.2 Leading European Anti-counterfeiting Technologies Market Forecast 2012-2022
  6.2.3 Japanese Anti-counterfeiting Technologies Market Forecast 2012-2022
  6.2.4 Brazilian Anti-counterfeiting Technologies Market Forecast 2012-2022
  6.2.5 Russian Anti-counterfeiting Technologies Market Forecast 2012-2022
  6.2.6 Indian Anti-counterfeiting Technologies Market Forecast 2012-2022
    6.2.6.1 WHO to Help India Curb Low Quality Medicines
  6.2.7 Chinese Anti-counterfeiting Technologies Market Forecast 2012-2022

7. TRENDS IN PHARMACEUTICAL ANTI-COUNTERFEITING TECHNOLOGIES 2012-2022

7.1 SWOT Analysis for Pharmaceutical Anti-counterfeiting Technologies 2012-2022
  7.1.1 Drivers and Restraints For Pharmaceutical Anti-counterfeiting Technologies 2012-2022
7.2 Market Strengths
  7.2.1 Significant Interest from Pharmaceutical Industry in Tackling Counterfeiting
    7.2.1.1Pfizer
    7.2.1.2 Johnson & Johnson
    7.2.1.3 GlaxoSmithKline
    7.2.1.4 Sanofi
    7.2.1.5 Novartis
    7.2.1.6 AstraZeneca
  7.2.2 Organisations Tackling Pharmaceutical Counterfeiting
    7.2.2.1 Anti-counterfeiting and Product Protection Programme (A-CAPPP)
    7.2.2.2 Anti-counterfeiting Group (ACG)
    7.2.2.3 Brazil's National Health Surveillance Agency (ANVISA)
    7.2.2.4 Canadian Anti-counterfeiting Network (CACN)
    7.2.2.5 Center for Healthcare Supply Chain Research
    7.2.2.6 European Alliance for Access to Safe Medicines (EAASM)
    7.2.2.7 European Federation of Pharmaceutical Industries and Associations (EFPIA)
    7.2.2.8 International Anti-counterfeiting Coalition (IACC)
    7.2.2.9 International Authentication Association (IAA)
    7.2.2.10 The Pharmaceutical Security Institute (PSI)
  7.2.3 Manufacturer and Distributor Liability for Counterfeit Products
  7.2.4 Increased Supply Chain Efficiency using Track-and-Trace Solutions
    7.2.4.1 Potential to Reduce Costs of Pharmaceutical Returns and Recalls
  7.2.5 New Technologies are Available
7.3 Market Weaknesses
  7.3.1 Unproven Commercial Benefits of Anti-counterfeiting Technologies
  7.3.2 Challenges in Proving the Commercial Benefits of Anti-counterfeiting Technologies
  7.3.3 Lack of Industry-Wide Standards Will Impede Adoption of Technology
  7.3.4 Poor Cooperation Between a Country's Governmental Organisations Aids Drug Counterfeiters
  7.3.5 Reliability of Anti-counterfeiting Technology and Integration into Manufacturing Processes
7.4 Market Opportunities and Threats
  7.4.1 Developing Countries Will Continue to See High Counterfeit Activity
  7.4.2 Counterfeiters - One Step Ahead?
  7.4.3 Anti-counterfeiting Technologies to Prevent Online Fraud
7.5 STEP Analysis for Pharmaceutical Anti-counterfeiting Technology 2012-2022
7.6 Social Factors
  7.6.1 Public Awareness and Education
  7.6.2 Corruption Is a Tool of the Counterfeiter
  7.6.3 Security of Information
  7.6.4 The Weak Enforcement of Legislation
7.7 Technological Developments
  7.7.1 Nanotechnology - Invisible 2D Barcodes
  7.7.2 Smartphone Applications and Consumer Empowerment
  7.7.3 The US FDA Develops New Detection Device
  7.7.4 Bokode - a Replacement for Barcodes?
  7.7.5 SigNature DNA
7.8 Economic Pressures
  7.8.1 Implementation Costs of Anti-counterfeiting Technologies
  7.8.2 Anti-counterfeiting Technologies Require R&D Investment
7.9 Political Issues
  7.9.1 Anti-Counterfeiting Trade Agreement (ACTA)
  7.9.2 World Health Organization - IMPACT Programme
  7.9.3 The Fagan Civil Case
    7.9.3.1 Effects of Litigation on Players in the Drug Supply Chain
  7.9.4 New Supply Chain Security Legislation
  7.9.5 E-pedigree Legislation: US
    7.9.5.1 E-pedigree: What Does it Entail?
    7.9.5.2 E-pedigree Solutions
  7.9.6 European Falsified Medicines Directive
  7.9.7 UK MHRA Launches New Anti-counterfeiting Strategy

8. OPINIONS FROM OUR SURVEY: RESEARCH INTERVIEWS

8.1 Interview with Sarah Hein, Marketing Director, InkSure Technologies
  8.1.1 Thoughts on the Current Pharmaceutical Counterfeiting Situation
  8.1.2 Global Counterfeiting Threats
  8.1.3 Combating Pharmaceutical Counterfeiting
  8.1.4 Thoughts on Drivers and Threats in the Pharmaceutical Anti-counterfeiting Market
8.2 Interview with Dr Fred Jordan, Co-founder and CEO of AlpVision
  8.2.1 The Pharmaceutical Counterfeiting Situation
  8.2.2 Pharmaceutical Anti-counterfeiting Technologies
  8.2.3 Thoughts on Challenges Facing Anti-counterfeiting Technologies
  8.2.4 The Responsibility of Counterfeit Prevention
  8.2.5 Thoughts on Anti-counterfeiting Market Drivers

9. CONCLUSIONS

9.1 The World Pharmaceutical Anti-counterfeiting Technologies Market 2012-2022
9.2 The US Will Continue to Dominate
9.3 Legislation Will Ensure Track-and-Trace Solutions Remain Market Leaders
9.4 Regulation of Internet Pharmacies Must Improve
9.5 Closing Thoughts on the Industry and Market

List Of Tables

LIST OF TABLES

Table 1.1 Currency Exchange Rates, 2011
Table 2.1 Worldwide Incidents of Drug Counterfeiting, 2009-2011
Table 2.2 Types of Counterfeit Drugs
Table 3.1 Leading Anti-counterfeiting Holographic Labelling Manufacturers, 2012
Table 3.2 Leading Manufacturers of Anti-counterfeiting Security Inks, 2012
Table 3.3 Leading Manufacturers of Pharmaceutical Taggants, 2012
Table 3.4 Leading Manufacturers of RFID Tags, 2012
Table 4.1 Angstrom Technologies Product Range, 2012
Table 4.2 Avery Dennison: Selected RFID Products, 2012
Table 4.3 InkSure Technologies Product Range, 2012
Table 4.4 InkSure Technologies Revenue, 2009-2011
Table 4.5 Selected Intermec Product Lines, 2012
Table 4.6 Intermec Revenue, 2009-2011
Table 4.7 Selected UPM Raflatac Products, 2012
Table 4.8 Zebra Technologies Revenue, 2009-2011
Table 5.1 Pharmaceutical Anti-counterfeiting Technologies: World Market Forecast by Sector, ($m), AGR (%), CAGR (%), 2011-2022
Table 5.2 Pharmaceutical Anti-counterfeiting: World Market Shares by Sector (%), 2011, 2017 & 2022
Table 5.3 Security Printing Revenue Forecast ($m), AGR (%), CAGR (%), 2011-2022
Table 5.4 RFID Revenue Forecast ($m), AGR (%), CAGR (%), 2011-2022
Table 5.5 Taggants Revenue Forecast ($m), AGR (%), CAGR (%), 2011-2022
Table 5.6 Hologram/OVD Revenue Forecast ($m), AGR (%), CAGR (%), 2011-2022
Table 5.7 Other Revenue Forecast ($m), AGR (%), CAGR (%), 2011-2022
Table 6.1 Pharmaceutical Anti-counterfeiting Technologies: World Market Forecast by Region, ($m), AGR (%), CAGR (%), 2011-2022
Table 6.2 Pharmaceutical Anti-counterfeiting Technologies: World Market Shares by Region (%), 2011, 2017 & 2022
Table 6.3 US Pharmaceutical Anti-counterfeiting Market Forecast ($m), AGR (%), CAGR (%), 2011-2022
Table 6.4 EU5 Pharmaceutical Anti-counterfeiting Market Forecast ($m), AGR (%), CAGR (%), 2011-2022
Table 6.5 Japanese Pharmaceutical Anti-counterfeiting Market Forecast ($m), AGR (%), CAGR (%), 2011-2022
Table 6.6 Brazilian Pharmaceutical Anti-counterfeiting Market Forecast ($m), AGR (%), CAGR (%), 2011-2022
Table 6.7 Russian Pharmaceutical Anti-counterfeiting Market Forecast ($m), AGR (%), CAGR (%), 2011-2022
Table 6.8 Indian Pharmaceutical Anti-counterfeiting Market Forecast ($m), AGR (%), CAGR (%), 2011-2022
Table 6.9 Chinese Pharmaceutical Anti-counterfeiting Market Forecast ($m), AGR (%), CAGR (%), 2011-2022
Table 7.1 Pharmaceutical Anti-counterfeiting Technologies: SWOT Analysis, 2012-2022
Table 7.2 Selected Counterfeiting Activities, 2009-2012
Table 9.1 World Pharmaceutical Anti-counterfeiting Market Forecast ($m), AGR (%), CAGR (%), 2011-2022

List Of Figures

LIST OF FIGURES

Figure 2.1 Worldwide Incidents of Drug Counterfeiting, 2009-2011
Figure 2.2 Flow Chart of the Route Taken by Counterfeit Drugs Entering the Legal Supply Chain
Figure 3.1 Hologram Anti-counterfeiting Technologies: Drivers and Restraints, 2012-2022
Figure 3.2 Taggant Anti-counterfeiting Technologies: Drivers and Restraints, 2012-2022
Figure 3.3 RFID Anti-counterfeiting Technologies: Drivers and Restraints, 2012-2022
Figure 3.4 Barcode Anti-counterfeiting Technologies: Drivers and Restraints, 2012-2022
Figure 4.1 InkSure Technologies Revenue, 2009-2011
Figure 4.2 Intermec Revenue, 2009-2011
Figure 4.3 Zebra Technologies Revenue, 2009-2011
Figure 5.1 Pharmaceutical Anti-counterfeiting Technologies: World Market Forecast ($m), 2011-2022
Figure 5.2 Pharmaceutical Anti-counterfeiting Technologies: World Market Forecast by Sector ($m), 2011-2022
Figure 5.3 Pharmaceutical Anti-counterfeiting: World Market Shares by Sector (%), 2011
Figure 5.4 Pharmaceutical Anti-counterfeiting: World Market Shares by Sector (%), 2017
Figure 5.5 Pharmaceutical Anti-counterfeiting: World Market Shares by Sector (%), 2022
Figure 5.6 Security Printing Revenue Forecast ($m), 2011-2022
Figure 5.7 5 RFID Revenue Forecast ($m), 2011-2022
Figure 5.8 Taggants Revenue Forecast ($m), 2011-2022
Figure 5.9 Hologram/OVD Revenue Forecast ($m), 2011-2022
Figure 5.10 Other Revenue Forecast ($m), 2011-2022
Figure 6.1 Pharmaceutical Anti-counterfeiting Incidents by Region (%), 2008 & 2011
Figure 6.2 US, EU5 and Japan: Pharmaceutical Anti-counterfeiting Technologies Forecast ($m), 2011-2022
Figure 6.3 Brazil, Russia, India and China: Pharmaceutical Anti-counterfeiting Technologies Forecast ($m), 2011-2022
Figure 6.4 Pharmaceutical Anti-counterfeiting: World Market Shares by Region (%), 2011
Figure 6.5 Pharmaceutical Anti-counterfeiting: World Market Shares by Region (%), 2017
Figure 6.6 Pharmaceutical Anti-counterfeiting: World Market Shares by Region (%), 2022
Figure 6.7 US Pharmaceutical Anti-counterfeiting Market Forecast ($m), 2011-2022
Figure 6.8 EU5 Pharmaceutical Anti-counterfeiting Market Forecast ($m), 2011-2022
Figure 6.9 Japanese Pharmaceutical Anti-counterfeiting Market Forecast ($m), 2011-2022
Figure 6.10 Brazilian Pharmaceutical Anti-counterfeiting Market Forecast ($m), 2011-2022
Figure 6.11 Russian Pharmaceutical Anti-counterfeiting Market Forecast ($m), 2011-2022
Figure 6.12 Indian Pharmaceutical Anti-counterfeiting Market Forecast ($m), 2011-2022
Figure 6.13 Chinese Pharmaceutical Anti-counterfeiting Market Forecast ($m), 2011-2022
Figure 7.1 Pharmaceutical Anti-counterfeiting Technologies: Drivers, 2012-2022
Figure 7.2 Pharmaceutical Anti-counterfeiting Technologies: Restraints, 2012-2022
Figure 7.3 Anti-counterfeiting Strategies in the US and Europe, 2012
Figure 9.1 World Pharmaceutical Anti-counterfeiting Market Forecast ($m): Total Market, Security Printing and RFID Segments, 2011-2022

COMPANIES LISTED

3M
Actavis
Adhesives Research
Ahura Scientific
Alfred P. Sloan Foundation
Alien Technologies
AlpVision
Altegrity Risk International
American Academy of Pediatrics (AAP)
AmerisourceBergen
Angstrom Technologies
Anti-Counterfeiting and Product Protection Programme (A-CAPPP)
Anti-Counterfeiting Group (ACG)
Apoteket
Applied DNA Sciences
ARmark Authentication Technologies
AstraZeneca
Australian Therapeutic Goods Administration (TGA)
Authentix
Automation
Avery Dennison
Axway
Baxter
Camdata
Canadian Anti-Counterfeiting Network (CACN)
Capsugel
Cellular Bioengineering
Center for Healthcare Supply Chain Research
Center for Medicine in the Public Interest (US)
CFC International
Chesapeake
Colorcon
Cortegra
Covectra
DePuy Orthopaedic
Digital China
Domino
Drugs Standard Control Organisation
DuPont
Ecole Polytechnique Fédérale de Lausanne (EPFL)
European Alliance for Access to Safe Medicines (EAASM)
European Commission
European Directorate for the Quality of Medicines and Healthcare (EDQM),
European Federation of Pharmaceutical Industries and Associations (EFPIA)
European Fine Chemicals Group (EFCG)
European Medicines Agency
Everest Holovisions
Federation Council (Russia)
Genetech
GlaxoSmithKline (GSK)
Google
Healthcare Distribution Management Association (HDMA)
Heart UK
Hologram Industries
Holomex
HOMAI (hologram manufactures association of India)
Image Solution
Impinj
IMS Health
Ingenia Technology
InkSure Technologies
Interface Mechanisms
Intermec
International Anti-counterfeiting Association (IAA)
International Anti-Counterfeiting Coalition (IACC)
International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
International Ink Company
International Medical Products Anti-Counterfeiting Taskforce (IMPACT)
Interpol
Japanese Pharmaceutical Manufacturers Association (JPMA)
Johnson & Johnson
Kodak
Loughborough University
Massachusetts Institute of Technology (MIT)
Medicines and Healthcare products Regulatory Agency (MHRA)
Medicrime Convention Council
Millennium Pharmaceuticals
Menasha Corporation
Microtag Temed
Microtrace Solutions
Motorola
NanoGuardian
NanoInk
National Association of Boards of Pharmacy (NABP)
National Health Surveillance Agency (ANVISA)
Neri Labels
Nokia
Novartis
Novavision
OEP Technologie
One Equity Partners
OpSec Security
Pacific Holographics
Partner for Safe Medicines (PSM) India
Pera Innovation
Pfizer
Pharmaceutical Research and Manufacturers of America (PhRMA)
PharmaSecure
Polychromax
Quality Brands Protection Committee (QBPC) China
Raflatac
Reckitt Benckiser
Riverside Partners
Roche
Royal Pharmaceutical Society of Great Britain (RPSGB)
Samsung
Sanofi
Savi Technology
ScanSource
Scientific Protein Laboratories (SPL)
SICPA
Siemens
Smartrac
South Dakota School of Mines and Technology
State Food and Drug Administration (SFDA)
Sun Chemical
Symbol Technologies
Systech
Tagsys RFID
Teva
Texas Instruments
The International Hologram Manufacturers Association
The Patients Association (UK)
The Pharmaceutical Security Institute (PSI)
Thermo Scientific
TruTag Technologies
United Nations
University of South Dakota
UPM
UPM Kymmene
UPM Raflatac
UPM Rafsec
US Center for Safe Internet Pharmacies (CSIP).
US FDA
Vocollect
Voxtel
Webscan
World Customs Organization
World Health Organization (WHO)
World Intellectual Property Organization (WIPO)
Zebra Technologies